NB
Neurocrine
NBIX·NASDAQSan Diego CAFounded 19921,700 employees
Large CapbiotechPublicNeurologyEndocrinology
Platform: Neuroactive
Market Cap
$14B
All Drugs
5
Clinical Trials
7
Failed / Terminated
2
FDA Approved
2
Stock Price & Catalysts (NBIX)
Loading NBIX stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevifotisoran | NBI-3156 | Approved | 1 | CD47 | NarcolepsyCKD | ||
| Miritinib | NBI-136 | Phase 3 | 1 | TIGIT | LNPNH | ||
| NBI-3153 | NBI-3153 | Approved | 3 | Aβ | Bladder Ca | ||
| NBI-408 | NBI-408 | Phase 2/3 | 1 | KRASG12D | Breast Ca | ||
| Zanurapivir | NBI-792 | NDA/BLA | 1 | EGFR | LGS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)